Open AccessRace and prognosis after myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.
Author(s) -
Herman A. Taylor,
Bernard R. Chaitman,
W J Rogers,
Morton J. Kern,
Michael L. Terrin,
Frank V. Aguirre,
George Sopko,
R. McMahon,
Richard N. Ross,
EG Bovill
Publication year - 1993
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.88.4.1484
Subject(s) - medicine , timi , myocardial infarction , thrombolysis , diabetes mellitus , fibrinogen , cardiology , surgery , endocrinology
To better understand the role of race/ethnicity in survival after acute myocardial infarction, we compared clinical and laboratory data, response to thrombolytic therapy, and clinical outcome in 2885 patients participating in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Trial among three groups of patients (2564 whites, 174 blacks, and 147 Hispanics).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom